In order to rule out a potential role for TRIM8 deficit in determining the resistance of the ccRCC to chemotherapy due to prevention of p53 full activation, we evaluated whether the recovery of TRIM8 expression levels renders the renal tumour cells more sensitive to conventional chemotherapy. The gene discussed is TRIM8; the disease is nonpapillary renal cell carcinoma.